BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schumacher L, Leino AD, Park JM. Tacrolimus intrapatient variability in solid organ transplantation: A multiorgan perspective. Pharmacotherapy 2021;41:103-18. [PMID: 33131078 DOI: 10.1002/phar.2480] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Anger LB, Doligalski CT. Solid organ transplant pharmacotherapy: Complicated and continually changing. Pharmacotherapy 2021;41:4-5. [PMID: 33598986 DOI: 10.1002/phar.2492] [Reference Citation Analysis]
2 Santulario Verdú L, García-romero E, Díez-lópez C. Impacto clínico de la variabilidad en la concentración sanguínea de inhibidores de calcineurina en trasplante cardiaco: una espada de doble filo. Revista Española de Cardiología 2022;75:112-4. [DOI: 10.1016/j.recesp.2021.08.019] [Reference Citation Analysis]
3 De Nicolò A, Pinon M, Palermiti A, Nonnato A, Manca A, Mula J, Catalano S, Tandoi F, Romagnoli R, D'Avolio A, Calvo PL. Monitoring Tacrolimus Concentrations in Whole Blood and Peripheral Blood Mononuclear Cells: Inter- and Intra-Patient Variability in a Cohort of Pediatric Patients. Front Pharmacol 2021;12:750433. [PMID: 34803692 DOI: 10.3389/fphar.2021.750433] [Reference Citation Analysis]
4 Pierce DR, West-Thielke P, Hajjiri Z, Gaitonde S, Tzvetanov I, Benedetti E, Lichvar AB. Clinical Implications of Tacrolimus Time in Therapeutic Range and Intrapatient Variability in Urban Renal Transplant Recipients Undergoing Early Corticosteroid Withdrawal. Transplant Direct 2021;7:e698. [PMID: 34036168 DOI: 10.1097/TXD.0000000000001155] [Reference Citation Analysis]
5 Tan T, Bunnapradist S. Comparing the pharmacokinetics of extended-release tacrolimus (LCP-TAC) to immediate-release formulations in kidney transplant patients. Expert Opin Drug Metab Toxicol 2021;17:1175-86. [PMID: 34459696 DOI: 10.1080/17425255.2021.1974399] [Reference Citation Analysis]